Discover how advanced Battery Management Systems (BMS) are enhancing electric vehicle efficiency and reliability by embedding ...

BioCT, Connecticut's life sciences trade organization, is pleased to announce the appointment of four distinguished ...

Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial OfficerMr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing ...

Trufla is officially launching PolicyPro -a dedicated offshore back-office and policy administration service designed to help ...

The next wave of AI-enabled operations is reshaping how data centres are run, promising sharper efficiency, tighter security ...

On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...

North America held a dominan Market position, capturing more than a 33.6% share, holding USD 1.4 Billion revenue.

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...

The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...

The FDA’s Office of Prescription Drug Promotion asserted that BeOne’s Teams backgrounds made benefit claims without providing ...

Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for ...